Navigation Links
Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea
Date:11/24/2008

HANGZHOU, China, Nov. 24 /PRNewswire/ -- Tigermed Consulting Co., Ltd., a leading Contract Research Organization (CRO) in China, announced that it has established strategic partnerships with two leading CROs, OCT in Russia and LSK in Korea respectively to integrate resources for the expansion and establishment of a global clinical trial network. This new strategic alliance spurs Tigermed to provide more extensive and comprehensive outsourcing clinical service for Multinational Pharmaceutical Corporations and Local Research Institutions in the research and development of innovative drugs.

Tigermed currently is ranked one of the largest Contract Research Organizations (CRO) in China, with a leading position in the Chinese clinical trial industry. Tigermed, staffed with a team of 100 professionals serving more than 150 local and global clients, has 15 offices in China and one office in the USA and a liaison office in Europe. The company's therapeutic strengths lie in areas such as oncology, biological vaccines, hepatitis, digestive system, cardiovascular and infectious diseases, in which Tigermed accumulated significant experience. Financed by Qiming Ventures, an internationally renowned venture capital organization, Tigermed now enters into a period of rapid expansion.

OCT, headquartered in Saint Petersburg, is a Russian CRO dedicated to clinical studies in Russia, Ukraine and other Eastern European countries. This strategic alliance with OCT facilitates Tigermed's expansion into these countries, and provides registration and clinical research services for Chinese Pharmaceutical Enterprises that have plans to enter into Eastern European markets.

LSK, headquartered in Seoul, is a leading CRO in Korea providing all stages of clinical research services in Korea, Japan, Taiwan and Malaysia. The strategic partnership with LSK enables Tigermed to extend its service capabilities into Asia Pacific. Tigermed will now be able to provide complete regulatory and clinical research services to Pharmaceutical Companies interested in the wider Asian market.

Industry insiders expect the union between leading CROs to facilitate Tigermed's expansion into the various markets and establish its reputation internationally in clinical research and product development. OCT and LSK plan to establish an international customer base through Tigermed's established profile and capabilities in developing new pharmaceutical products.

In addition its clinical research capabilities, TigerMed is recognized in the industry as a specialist for innovative Drug Services. Initial medical discoveries have been carried forward by Tigermed to the path of product development, which turns ideas into realities.

"By forming these strategic alliances, Tigermed takes the pioneering position in exploring business potential and achieving breakthroughs in global service capabilities through cross-border cooperation, which is a significant move for China's CROs. Strategic collaboration is one of our important tactics to expand global business, and this type of partnering becomes an essential part of our international strategy," comments Ms Cao Xiaochun, Vice President of Tigermed, who looks forward to establishing Tigermed as the leading CRO in Asia Pacific within three years, "Tigermed nurtures talent; and strategic partnering will allow great strides forward in the globalization of our talents, which will in the long run, fulfill the ambitions of Tigermed. Tigermed values human capital and seeks to develop this resource globally."

    For more information, please contact:

     Zeng Haiyan
     Tel:   +86-571-8998-6792
     Email: pr@tigermed.net

'/>"/>
SOURCE Tigermed Consulting Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
2. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
3. Fat transforms vitamin C from good cop into bad cop
4. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
5. Care reforms raise concerns over patient access to GP services
6. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
7. Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
10. Governor Rendell Calls for Prompt Action on Prescription for Pennsylvania, Cover All Pennsylvanians Health Care Reforms
11. How Candida albicans transforms from its normally benign form into life-threatening form
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that ... Denville, NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their ... orthodontics can cause for some patients, which is why they offer the latest in ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... Uniform ... scrub collection featuring seven new products designed to create tailored looks and athleisure-inspired outfits. ... polyester and cotton easy care stretch twill. , With trendy looks hitting the medical ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN ... whose insight and expertise in healthcare will provide invaluable direction for the company,” ...
(Date:6/19/2017)... New York, NY (PRWEB) , ... June 19, 2017 , ... ... and this year, it’s going to be a humdinger. A warm winter and wet ... devour summer wedding guests. “No one wants to be swatting away pesky mosquitoes when ...
(Date:6/19/2017)... ... June 19, 2017 , ... StratusLIVE, LLC, a leading provider ... new and improved features to their Workplace Giving platform including an all ... of national campaigns. The latest release also includes enhancements to dashboards, reporting, ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... The Cincinnati location of Diplomat Specialty ... has been awarded a Top Workplaces 2017 honor ... based on an employee survey administered by WorkplaceDynamics, LLC, a ... survey measures several aspects of workplace culture, including alignment, execution, ... ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: